Sakai, Japan

Hiromu Kochi


Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 297(Granted Patents)


Location History:

  • Sakai, JA (1976)
  • Sakai, JP (1979 - 1992)

Company Filing History:


Years Active: 1976-1992

Loading Chart...
31 patents (USPTO):Explore Patents

Title: Hiromu Kochi – Innovator in Pharmaceutical Chemistry

Introduction

Hiromu Kochi, a distinguished inventor based in Sakai, Japan, holds an impressive portfolio of 31 patents. He has made significant contributions to the field of pharmaceutical chemistry, particularly focusing on cephalosporin intermediates and complex compounds that have potential therapeutic applications.

Latest Patents

Kochi's latest patents include innovative formulations such as the syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds. Additionally, he has developed a compound characterized by a specific formula where R² represents carboxy(lower)alkyl or protected carboxy(lower)alkyl, and R⁶ is amino or a protected amino group, along with its reactive derivative at the carboxy group. This work emphasizes the transformation of carboxy groups into reactive N-acylating groups, enhancing the potential for pharmaceutical development.

Career Highlights

Currently, Hiromu Kochi is associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to push the boundaries of innovation in drug development. His contributions have greatly influenced the synthesis of cephalosporin intermediates, which are crucial in the creation of antibiotics.

Collaborations

Throughout his career, Kochi has worked alongside esteemed colleagues such as Takao Takaya and Takashi Masugi. Their collaborations reflect a commitment to advancing pharmaceutical science and fostering a collaborative research environment within the industry.

Conclusion

Hiromu Kochi's work exemplifies the spirit of innovation in the pharmaceutical sector. His extensive list of patents and ongoing contributions significantly enhance our understanding and development of crucial medical compounds, marking him as a vital figure in contemporary pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…